FYC-56235-72870
2 vaccinations
7 coded responses
17 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 222 / VA
- Registered
- 2021-05-11
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-05-10
Dose 1 — Moderna
-
2021-05-11
Registered in v-safe
-
2021-05-11
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-12
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-05-17
Health check-in — day 7, dose 1Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-26
-
2021-06-14
Survey response — day 35, dose 1MedDRA: Arthralgia, Fatigue, Rhinorrhoea, Sneezing — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Fatigue joint pain sneezing and runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-14
Report sent to call center — day 35, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-21
Dose 2 — Moderna
-
2021-06-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-06-23
-
2021-06-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-06-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal painAdult check-in
-
2021-06-28
Health check-in — day 7, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-07-05
Survey response — day 14, dose 2MedDRA: Pre-existing disease, Rash — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Rashes eczema flare upsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-12
Survey response — day 21, dose 2MedDRA: Asthma, Eczema, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Eczema symptoms and asthma has flared up tremendously. I never experienced this during this time of year in years beforeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-19
Survey response — day 28, dose 2MedDRA: Chest pain, Respiratory tract congestion, Sneezing — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Chest pains sneezing and congestionMedDRA releases: 2024-11 · check-in free text available
-
2021-08-02
Survey response — day 42, dose 2MedDRA: Arthralgia, Asthenia, Eczema, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Weakness , joint pain, flared up eczemaMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-20
Survey response — 3 months, dose 2MedDRA: Eye swelling, Hypersensitivity, Rash — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I have new allergic reactions Im not sure to watch I can not afford test but randomly wake up swollen eyes and rashes since vaccinationMedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Survey response — 6 months, dose 2MedDRA: Autoimmune disorder — Feeling: Poor · Be unable to work or attend schoolFree text: Autoimmune disease - in process of exact diagnosis that may be mixed connective tissue diseaseMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-10 | Moderna | |
| 2 | 2021-06-21 | Moderna | No |
Call center
1 call center case
1 unsuccessful
VAERS report filed, before or during a call: 1
Free text
Release 9 — day 35, dose 1
Symptoms: Fatigue joint pain sneezing and runny nose
Release 9 — day 14, dose 2
Symptoms: Rashes eczema flare ups
Release 9 — day 21, dose 2
Symptoms: Eczema symptoms and asthma has flared up tremendously. I never experienced this during this time of year in years before
Release 9 — day 28, dose 2
Symptoms: Chest pains sneezing and congestion
Release 9 — day 42, dose 2
Symptoms: Weakness , joint pain, flared up eczema
Release 9 — 3 months, dose 2
Symptoms: I have new allergic reactions Im not sure to watch I can not afford test but randomly wake up swollen eyes and rashes since vaccination
Release 10 — 6 months, dose 2
Symptoms: Autoimmune disease - in process of exact diagnosis that may be mixed connective tissue disease
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Asthenia | ✓ | · | ✓ |
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Autoimmune disorder | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Eczema | ✓ | ✓ | ✓ |
| SD | Eye swelling | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release